Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New York, USA, May 18, 2022 (GLOBE NEWSWIRE) -- Oncolytic Virus Cancer Therapy Pipeline Shows Rapid Progress in Clinical Trials, Assesses DelveInsight Oncolytic Virus Cancer Therapy Pipeline...
-
New York, USA, May 17, 2022 (GLOBE NEWSWIRE) -- The Spinal Decompression/Traction Devices Market is Anticipated to Reach USD 4.91 Billion with a CAGR of 4.24% During the Study Period (2018-26) |...
-
New York, USA, May 16, 2022 (GLOBE NEWSWIRE) -- Extensive Stage Small Cell Lung Cancer Pipeline Review | Clinical Trial Analysis by DelveInsight First-line therapies in the treatment of...
-
New York, USA, May 12, 2022 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market to Witness Tremendous Growth with a CAGR of 7.38% During the Study Period (2019-27) |...
-
New York, USA, May 11, 2022 (GLOBE NEWSWIRE) -- Chronic Hepatitis B Pipeline Analysis: Emerging Therapies, Key Companies, and Treatment Outlook | DelveInsight Chronic Hepatitis B Pipeline...
-
New York, USA, May 10, 2022 (GLOBE NEWSWIRE) -- Myopia Treatment Devices Market is Expected to Escalate at a CAGR of 7.57% During the Study Period (2019-27), Assesses DelveInsight The Myopia...
-
New York, USA, May 09, 2022 (GLOBE NEWSWIRE) -- Allergic Rhinitis Pipeline To Progress With Novel and Emerging Drugs, Analyzes DelveInsight Allergic Rhinitis Pipeline involves 32+ key companies...
-
New York, USA, May 05, 2022 (GLOBE NEWSWIRE) -- The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight The...
-
New York, USA, May 04, 2022 (GLOBE NEWSWIRE) -- Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight Tuberculosis (TB) is a chronic condition and has become a global disease...
-
New York, USA, May 03, 2022 (GLOBE NEWSWIRE) -- The Global Cryoablation Devices Market to Witness Robust Expansion at a CAGR of 8.8% During the Study Period (2019-27), Assesses DelveInsight The...